5 Key Takeaways

• 1

  The FDA approved Abbott’s TactiFlex Duo Ablation Catheter for patients with challenging atrial fibrillation cases.

• 2

  TactiFlex Duo can deliver pulsed field ablation or radiofrequency energy, individually or in combination.

• 3

  The catheter integrates with Abbott’s EnSite X EP system, which creates 3D heart maps and provides real-time data.

• 4

  Favorable safety and effectiveness outcomes were reported in a study involving patients with paroxysmal AFib.

• 5

  Abbott plans to begin TactiFlex Duo cases soon, with broader US commercial adoption expected in the coming weeks.